Feedback / Questions
Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories
Bioequivalence study of sacubitril/valsartan sodium tablets
(chinadrugtrials.org.cn)
-
Oct 13, 2026 -
P=N/A | N=84 | Not yet recruiting | Sponsor: Taikang Haien Pharmaceutical Co., Ltd.
New trial
•
Cardiovascular • Heart Failure • Hypertension
https://www.chinadrugtrials.org.cn//clinicaltrials.searchlistdetail.dhtml?id=7e70cbc537a543c1a5f77d4c02a65e69
Oct 13, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next